Welcome to European Pharmaceutical Review. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
Site name
Mast navigation
  • Become a member
  • Sign In
Search our site
Menu
Close menu
  • Home
  • News
  • Bioprocessing
  • QA
  • Topics
    • Back to parent navigation item
    • Topics
    • Analytical and bioanalysis
    • Bioprocessing and biomanufacturing
    • Quality, microbiology and contamination control
    • Regulation and compliance
    • Formulation and drug delivery
    • Packaging, containers and labelling
  • Webinars
  • Whitepapers
  • Reports
  • Publications
  • Home
  • News
  • Bioprocessing
  • QA
  • Topics
      • Analytical and bioanalysis
      • Bioprocessing and biomanufacturing
      • Quality, microbiology and contamination control
      • Regulation and compliance
      • Formulation and drug delivery
      • Packaging, containers and labelling
    • shutterstock_2093455450
      Eli Lilly doubles down on supply chain investment in Asia
    • shutterstock_1569359980
      Gilead adds to cell therapy portfolio with $8bn acquisition of Arcellx
    • Image
      Fujifilm's Lars Petersen on trust-based partnerships and a ‘people first’ culture
  • Webinars
  • Whitepapers
  • Reports
  • Publications
  • More navigation items

A to Z subjects

Find stories by subject. Use the A-Z options to view other subjects.

  • A to Z subjects
  • A to Z contributors
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • 0-9
  • All
V
  • Vabysmo (faricimab)
  • Vaccine Technology
  • vaccines
  • Valneva
  • ValSource
  • Van Hoang (Spark Therapeutics)
  • Vanessa Vasadi Figueroa
  • Vanflyta (quizartinib)
  • vanzacaftor/tezacaftor/deutivacaftor
  • Vas Narasimhan
  • Veklury
  • Vela
  • venetoclax
  • Ventolin (salbutamol)
  • Ventyx Biosciences
  • Veolia
  • Veolia Water Technologies & Solutions
  • vepdegestrant
  • Verified Market Reports
  • Verified Market Research
  • Verona Pharma
  • Vertex Pharmaceuticals
  • Verve Therapeutics
  • VERVE-102
  • Verzenio
  • Vevzuo
  • VG-3927
  • Viatris
  • Vicebio
  • ViiV Healthcare
  • Vimkunya (chikungunya vaccine (recombinant
  • Vinay Prasad
  • Vincenzo Gioia
  • viral infections
  • Virtual reality (VR)
  • Viruses
  • Vish Seshadri
  • Vitiligo
  • Vocabria (cabotegravir)
  • VTT Technical Research Centre of Finland
  • VVF Science
  • VWV
  • VXB-241
  • Vydura (rimegepant)
  • Vyjuvek (beremagene geperpavec)
  • VYJUVEK™ (beremagene geperpavec-svdt)
  • Vyvgart (efgartigimod alfa)
  • Topics
  • Analytical and bioanalysis
  • Bioprocessing and biomanufacturing
  • Quality, microbiology and contamination control
  • Regulation and compliance
  • Formulation and drug delivery
  • Packaging, containers and labelling
  • Advertising & Editorial
  • Advertising opportunities
  • Media planner
  • Advertising tech specs
  • Advisory board
  • Information for authors
  • Reuse policy
  • Information
  • About us
  • Company information
  • Careers
  • Terms and conditions
  • Privacy policy
  • Cookie policy
Leading the conversation in pharma manufacturing
Find us on social media:
  • Topics A-Z
  • Writers A-Z
  • © 2026 European Pharmaceutical Review

Site powered by Webvision Cloud